Is this you? Create Your Porfile
Avatar

Michael Gottfried

Schering AG

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Michael Gottfried is active.

Explore More

Publication

Featured researches published by Michael Gottfried.

Archive | 2000

Multi-stage method for producing gas-filled microcapsules

Uwe Budde; Andreas Briel; Georg Rössling; Kai Lovis; Wolfgang Schmidt; Hans-Ulrich Moritz; Michael Gottfried; Jan-Peter Ingwersen

Archive | 2000

Mehrstufen-verfahren zur herstellung von gasgefüllten mikrokapseln

Andreas Briel; Uwe Budde; Michael Gottfried; Jan-Peter Ingwersen; Kai Lovis; Hans-Ulrich Moritz; Georg Rössling; Wolfgang Schmidt

Archive | 2009

The purest rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]piperazin-1-yl}-2,2-diphenylethan-1-one fumarate

Hilmar Weinmann; Matthias Schneider; Michael Gottfried

Archive | 2009

Preparation of and compositions comprising N-(2-aminophenyl)-4-[N-(pyridine-3-yl)methoxycarbonylaminomethyl]-benzamide (MS-275) polymorph B

Matthias Schneider; Michael Gottfried; Jens Geisler; Gabriele Winter

Archive | 2008

Method for producing the purest rac-1-{4-(2-hydroxy-3-(5-quinolyloxy)propyl) piperazin-1-yl}-2,2-diphenylethan-1-one fumarate and the product obtained therefrom

Matthias Schneider; Michael Gottfried; Hilmar Weinmann

Archive | 2004

Method for producing the purest rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl] piperazin-1-yl}-2,2-diphenylethan-1-one fumarate and the purest rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]piperazin-1-yl}-2,2-diphenylethan-1-one fumarate

Hilmar Weinmann; Matthias Schneider; Michael Gottfried

Archive | 2004

Process for the production of high-purity rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2-diphenylethan-1-one fumarate and high-purity rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]piperazin-1-yl}-2,2-diphenylethan-1-one fumarate

Hilmar Weinmann; Matthias Schneider; Michael Gottfried

Archive | 2004

Procede de production de fumarate ultrapur de rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]-piperazine-1-yle}2,2-diphenylethane-1-one et fumarate ultrapur de rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]-piperazine-1-yle}2,2-diphenylethane-1-one

Hilmar Weinmann; Matthias Schneider; Michael Gottfried

Archive | 2003

Verfahren zur Herstellung von reinstem rac-1{4-[2- Hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2-diphenylethan-1-one fumarat und reinstes rac-1{4-[2-Hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2

Hilmar Weinmann; Matthias Schneider; Michael Gottfried

Archive | 2003

A process for producing the purest rac-1 {4- [2- hydroxy-3- (5-quinolyloxy) propyl] -piperazin-1-yl} -2,2-diphenylethan-1-one fumarate and the purest rac-1 {4 - [2-hydroxy-3- (5-quinolyloxy) propyl] -piperazin-1-yl} -2,2

Michael Gottfried; Matthias Schneider; Hilmar Weinmann

Explore More

Collaboration

Dive into the Michael Gottfried's collaboration.

Top Co-Authors
Avatar

Matthias Schneider

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Hilmar Weinmann

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Andreas Briel

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Hans-Ulrich Moritz

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Jan-Peter Ingwersen

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Kai Lovis

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Uwe Budde

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors
Avatar

Wolfgang Schmidt

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Georg Rössling

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Gabriele Winter

Bayer Schering Pharma AG

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge